Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.
Blood. 2024 Apr 4;143(14):1399-1413. doi: 10.1182/blood.2023021349.
Blood. 2024.
PMID: 38194688
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.
Malighetti F, Arosio G, Manfroni C, Mauri M, Villa M, Manghisi B, Inzoli E, Rindone G, Zambrotta GPM, Civettini I, Guglielmana V, Ramazzotti D, Giudici G, Bombelli S, Perego R, Piazza R, Mologni L, Gambacorti-Passerini C.
Malighetti F, et al. Among authors: inzoli e.
Hemasphere. 2023 Feb 24;7(3):e852. doi: 10.1097/HS9.0000000000000852. eCollection 2023 Mar.
Hemasphere. 2023.
PMID: 36860269
Free PMC article.
No abstract available.
Item in Clipboard
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.
Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM.
Inzoli E, et al.
Eur J Haematol. 2023 Apr;110(4):354-361. doi: 10.1111/ejh.13910. Epub 2022 Dec 16.
Eur J Haematol. 2023.
PMID: 36480004
Item in Clipboard
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success.
Inzoli E, Aroldi A, Piazza R, Gambacorti-Passerini C.
Inzoli E, et al.
Am J Hematol. 2022 Aug;97(8):1075-1085. doi: 10.1002/ajh.26556. Epub 2022 Apr 12.
Am J Hematol. 2022.
PMID: 35384030
Free PMC article.
Review.
Item in Clipboard
Cite
Cite